Showing 7211-7220 of 23138 results for "".
Thyroid Cancer Detection
https://reachmd.com/programs/clinicians-roundtable/thyroid-cancer-detection/2125/Thyroid cancer has traditionally been difficult to accurately diagnose and re-detect in the case of a recurrence. Why is it so difficult to diagnose and have we made further progress in the ability to better identify the markers of thyroid cancer? Dr. Allan Siperstien of Cleveland Clinic FoundationOvercoming Barriers in Dry Eye Disease Care: Current and Emerging Options
https://reachmd.com/programs/eye-on-ocular-health/overcoming-barriers-in-dry-eye-disease-care-current-and-emerging-options/37275/Dry eye disease treatment is often constrained by issues like tolerability, dosing limitations, and inconvenient administration routes. However, recent innovations are paving the way for more comfortable and effective delivery options that better align with patient needs. Tune in to hear Dr. HoumanEvidence Base for First-Line Treatment Strategies for Endometrial Cancer and Delivering Guideline-Concordant Care
https://reachmd.com/programs/cme/Evidence-Base-for-First-Line-Treatment-Strategies-for-Endometrial-Cancer-and-Delivering-Guideline-Concordant-Care/39294/Multidisciplinary experts explore biomarker-driven strategies, immunotherapy, and personalized care in cervical and endometrial cancer management.ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
https://reachmd.com/programs/project-oncology/ctdna-guided-bladder-preservation-mibc/36309/Emerging evidence is redefining bladder preservation strategies in muscle-invasive bladder cancer, with circulating tumor DNA (ctDNA) offering a novel approach to response-adapted care. Joining Dr. Charles Turck to review findings from the phase II RETAIN trials, which highlight how ctDNA clearanceTargeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
https://reachmd.com/programs/project-oncology/ribosome-maturation-triple-negative-breast-cancer/48768/Triple-negative breast cancer (TNBC) remains one of the hardest subtypes to treat, with limited options and high relapse rates—so identifying new therapeutic targets is critical. In this AudioAbstract, Ryan Quigley spotlights research presented at the San Antonio Breast Cancer Symposium that implicaClinical Decision-Making in Metastatic Breast Cancer: Optimizing Sequencing Choices
https://reachmd.com/programs/frontlines-metastatic-breast-cancer/clinical-decision-making-in-metastatic-breast-cancer-optimizing-sequencing-choices/36434/Effective treatment sequencing in patients with metastatic breast cancer is critical for maximizing clinical benefit and maintaining quality of life. Ms. Ashley Baker sits down with Dr. Giancarlo Moscol to discuss how to approach sequencing decisions based on tumor biology, disease progreUnderstanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
https://reachmd.com/programs/neurofrontiers/understanding-schizophrenia-new-insights-on-prevalence-treatment-and-quality-of-life/32315/Explore findings from a recent study analyzing the prevalence of schizophrenia in the United States and critical challenges for patients.Bits from “Bullets and Brains”: The (Disregarded) Value of Vaccines
https://reachmd.com/programs/book-club/bits-from-bullets-and-brains-the-disregarded-value-of-vaccines/10719/Years ago, infectious diseases like measles were thought to be eliminated. But now, vaccine hesitancy is one of the top 10 threats to global health.What Do the Updated Medicare Payment Policies Mean for You?
https://reachmd.com/programs/perspectives-ama/what-do-the-updated-medicare-payment-policies-mean-for-you/10607/Join AMA President Dr. McAneny as she guides us through changes to the physician fee schedule and organized medicine’s response to these changes.JAMA: Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies
https://reachmd.com/programs/Audioabstracts/jama-noninvasive-prenatal-testing-and-incidental-detection-occult-maternal-malignancies/7628/Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies Diana W. Bianchi, MD; Darya Chudova, PhD; Amy J. Sehnert, MD; Sucheta Bhatt, MD; Kathryn Murray, MS; Tracy L. Prosen, MD; Judy E. Garber, MD; Louise Wilkins-Haug, MD, PhD; Neeta L. Vora, MD; Stephen Warsof, MD; Jam